This is a routine administrative filing for a securities quotation application on the ASX. No material financial or operational information was disclosed. Monitor for future clinical trial updates or capital raising events that could move the stock.
Price Chart
Executive Summary
Alterity Therapeutics filed a Form 6-K on July 1, 2026, solely to submit an application for quotation of securities (ATH) on the Australian Securities Exchange. The filing contains no financial data, no operational updates, and no material corporate events — it is a routine administrative step for a foreign private issuer listing additional securities on its home exchange.
Key Facts
- Filed Form 6-K on July 1, 2026, for the month of July 2026
- Exhibit 99.1 is an application for quotation of securities (ATH) on the Australian Securities Exchange
- No financial data, operational updates, or material corporate events disclosed
- Company is a development stage enterprise (clinical-stage biotech)
- Filing incorporated by reference into existing S-8 and F-3 registration statements
Financial Impact
No financial figures disclosed in the filing
Risk Factors
- No financial or operational data disclosed — filing provides no new information for valuation
- Company is a development-stage enterprise with no approved products or revenue
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001437749-26-022206 |
| Document: 0001437749-26-022206-index-headers.html | 0001437749-26-022206 |
| Document: 0001437749-26-022206-index.html | 0001437749-26-022206 |
| Document: 0001437749-26-022206.txt | 0001437749-26-022206 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.08 (+0.48%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.08 (−0.48%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.08 (−0.48%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.08 (−12.97%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.08 (−12.97%) |
Oct 19, 2026 8d ago | 6-K | $2.43 | awaiting T+60 | — | $2.08 (−14.40%) |
Oct 9, 2026 18d ago | 6-K | $3.12 | awaiting T+60 | — | $2.08 (−33.33%) |
Oct 5, 2026 21d ago | Press Release | $3.22 | awaiting T+60 | — | $2.08 (−35.40%) |
Oct 5, 2026 22d ago | 6-K | $3.22 | awaiting T+60 | — | $2.08 (−35.40%) |
Sep 25, 2026 4w ago | 6-K | $3.67 | awaiting T+60 | — | $2.08 (−43.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers